Skip to main content

Center

NIAMS P30 Centers Program (P30 - Clinical Trial Not Allowed)

Apply to Internal Competition // Limit: 1 // Tickets Available: 1 

Limiting Language
Only one application per institution is allowed.

Program Description
The overall goal of this program is to accelerate scientific discovery, improve research efficiency, and enhance the translation of research findings into improved health outcomes. Centers funded under this program will also foster multidisciplinary collaboration, support workforce development across career stages, and promote training in emerging areas such as data science, artificial intelligence, and implementation research. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS P30 Centers Program to support integrated research Centers within its mission areas of skin biology and diseases; bone, muscle, and orthopaedic research; and rheumatic diseases.

The NIAMS P30 Centers Program supports Centers that provide coordinated research infrastructure, shared resources, and methodological expertise to advance basic, translational, and clinical research.

These Centers are expected to integrate state-of-the-art research resources with capabilities that support clinical and translational research, including the development, testing, and dissemination of novel analytical methods, study designs, outcome measures, and data-driven approaches.

Full sponsor guidelines are linked here.

Funding Type
External Deadline
2/1/2027
Internal Deadline
Internal Time
5:00PM
Solicitation Type

Diabetes Research Centers (P30 Clinical Trial Optional)

Apply to Internal Competition // Limit: 1 // Tickets Available: 1

Limiting Language
Only one application per institution is allowed, as defined in Section III. 3. Additional Information on Eligibility. 

Please note, under Section III. 3, it states, "Applicant organizations may submit more than one application, provided that each application is scientifically distinct". NIH has clarified the first statement on limiting language, indicating a limit of one, is the correct one.

Purpose of Funding Opportunity
This Notice of Funding Opportunity (NOFO) invites applications for Diabetes Research Centers (DRCs) that are designed to support and enhance the national research effort in diabetes, its complications, and related endocrine and metabolic diseases. The purpose of this Centers program is to bring together basic and clinical investigators to enhance communication, multidisciplinary collaboration, and effectiveness of ongoing research in Diabetes Research Center topic areas. By providing shared access to specialized technical resources (research cores) and supporting a Pilot and Feasibility Program (P&F), DRCs are intended to create an environment that provides the capability for accomplishments greater than those that would be possible by individual research project grant support alone. New Center programs that bring in new approaches, propose unique scientific themes, or provide innovative resources are encouraged. Emphasis will be placed on Center programs that propose enhanced synergies with other NIDDK-funded programs as well as providing a rich mentoring environment for future diabetes researchers. 

Funding Type
External Deadline
1/27/2027
Internal Deadline
Internal Time
5:00PM
Solicitation Type

Cooperative Centers for Experimental Hematology (CCEHs) (U54- Clinical Trial Not Allowed)

No Applicants // Limit: 1 // Tickets Available: 1

Limiting Language
Applicant organizations may submit only one application.

Purpose
The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications for Centers within the NIDDK Cooperative Centers of Experimental in Hematology (CCEH) Program. Each Center will support one to three Biomedical Research Cores and an Administrative Core, including an Enrichment Program. Each Center is expected to work collaboratively with NIDDK, the Hematology Coordinating Center (HCC), and the other CCEH Centers. The CCEH Program is designed to increase access to critical research resources and expertise unique to nonmalignant hematology research. By providing innovative technology, resources, and expertise to the greater hematology research community, the program will serve as a national hub, aimed at recruiting and retaining both junior scientists just beginning their careers in the field as well as established investigators from other domains.

Funding Type
External Deadline
9/30/2026

Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional)

Limit: 1 // Tickets Available: 0

F. Speilberg (Family, Community and Preventive Medicine, COM-P)

Limiting Language
Only one application per institution (normally identified by having a unique DUNS number or NIH IPF number) is allowed, provided that each application is scientifically distinct.

Purpose
This Notice of Funding Opportunity (NOFO) invites applications from institutions/organizations that propose to establish core centers that are part of an integrated and existing program of nutrition and/or obesity research. The Nutrition Obesity Research Centers (NORC) program is designed to support and enhance the national research effort in nutrition and obesity. NORCs support three primary research-related activities: Research Core services, a Pilot and Feasibility (P and F) program, and a Scientific Catalyst program. All activities pursued by Nutrition Obesity Research Centers are designed to enhance the efficiency, productivity, effectiveness, and multidisciplinary nature of research in nutrition and obesity.

Funding Type
External Deadline
10/20/2026

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)

No Applicants // Limit: 1 // Tickets Available: 1

Limiting Language
Only one application per institution (normally identified by having a unique UEI or NIH IPF number) is allowed.

Purpose
This Notice of Funding Opportunity (NOFO) invites applications for a Research Coordinating Center (RCC) to participate in a consortium of clinical centers that will test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize risks of AOM use. Such intervention strategies should support the promotion of healthy growth and development; adequate nutritional status/intake, healthy eating and physical activity behaviors; mental health and well-being (e.g., body image, self-esteem, mood, etc.), and quality of life and be feasible to implement in clinical care settings. Priority areas include testing strategies to determine optimal developmental stage for AOM initiation, rate and amount of weight loss, AOM class, dose, frequency, and duration, and content and intensity of adjunct lifestyle therapies that may be imperative to ensure normal psychological and physical development and to potentially avoid lifelong dependence on AOMs. Investigators should also evaluate potential predictors of response/ nonresponse to various treatment strategies under evaluation. The clinical centers may conduct independent or multicenter trials but will collaborate on the development of protocols, use of common measures and data elements, use of a central laboratory and standardized procedures to collect data and biospecimens, and data analyses and manuscripts

The RCC will lead, manage, and harmonize efforts for the Consortium including 1) providing management and administrative support; 2) providing leadership and expertise on statistical design and analysis, 3) providing research coordination with a central laboratory, 4) harmonizing data collection methods and use of common data elements, 5) developing the database; 6) conducting data management and data analyses for Consortium studies; and 7) fostering research collaborations. This NOFO uses a cooperative agreement mechanism (U24) and runs in parallel with a companion NOFO (RFA-DK-27-121).

Full sponsor guidelines are linked here. 
 

Funding Type
External Deadline
10/9/2026

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)

No Applicants // Limit: 1 // Tickets Available: 1

Limiting Language
Only one application per institution (normally identified by having a unique UEI or NIH IPF number) is allowed.


Purpose
This Notice of Funding Opportunity (NOFO) invites applications from clinical centers to participate in a consortium to test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize risks of AOM use. Such intervention strategies should support the promotion of healthy growth and development; adequate nutritional status/intake, healthy eating and physical activity behaviors; mental health and well-being (e.g., body image, self-esteem, mood, etc.), and quality of life and be feasible to implement in clinical care settings. Priority areas include testing strategies to determine optimal developmental stage for AOM initiation, rate and amount of weight loss, AOM class, dose, frequency, and duration, and content and intensity of adjunct lifestyle therapies that may be imperative to ensure normal psychological and physical development and to potentially avoid lifelong dependence on AOMs.  Investigators should also evaluate potential predictors of response/ nonresponse to various treatment strategies under evaluation. The clinical centers may conduct independent or multicenter trials but will collaborate on the development of protocols, use of common measures and data elements, use of a central laboratory and standardized procedures to collect data and biospecimens, and data analyses and manuscripts. 

Full sponsor guidelines are linked here. 

Funding Type
External Deadline
10/9/2026

Rural Cooperative Development Grants

No Applicants // Limit: 1 // Tickets Available: 1

Limiting Language 
An eligible institution may not submit more than one application to this program as a lead institution. This includes applications from subordinate units under a parent institution. Additionally, eligible recipients may only receive funds for one award at a time. Prospective applicants are advised to contact their institutional sponsored projects office regarding processes used to select proposals for submission. For RFAP purposes, ‘parent institution’ refers to the single, legally distinct institution of higher education that oversees its colleges, schools, and departments. A separate UEI by itself does not automatically make a campus or unit a different institution. Some campuses, divisions, or administrative units within a university system may maintain their own UEIs for grants management purposes while still operating under the governance, accreditation, and legal identity of a single parent institution. In such cases, the parent institution, not the UEI, is the controlling factor in determining the one application limit. The one application limit applies to all subordinate units under the same institution. However, university systems with multiple independently accredited and governed institutions may submit one application per institution within the system. A multi campus university system may submit more than one application only if each campus is recognized as a distinct institution based on its own independent accreditation, governance structure, and institutional identity. Institutions that have received congressionally directed funding for research facility projects are not excluded from participation in this program. Such institutions may submit applications and compete for additional projects under this competitive funding opportunity. 

Cost Sharing Requirements
Applicants MUST provide at minimum a 1:1 matching contribution on a dollar-for-dollar basis for all Federal funds awarded under the RFAP. The non-Federal share must be paid in cash and may include funding from private sources or from units of State or local government. In-kind matching will not be considered. See 7 U.S.C. 390a(c)(2)(A). The full match amount must be budgeted in the application, with sources of funding clearly disclosed. Recipients may phase matching contributions, potentially synchronized with project construction milestones, or raise additional funds during the project period, provided that the Authorized Representative signs the award, thereby attesting to fulfill all match commitments. Matching costs must be incurred during the federal award period, align with 2 CFR 200.306 requirements (verifiable, allowable, not double counted, and included in the approved budget), and be properly documented and reported cumulatively via the SF425 Federal Financial Reports throughout and at the conclusion of the project Consistent with 48 U.S.C. 1469a, notwithstanding any other provision of law, in the case of American Samoa, Guam, the Virgin Islands, the Federated States of Micronesia, and the Northern Mariana Islands, NIFA will waive any requirement for local matching funds under $200,000 (including in-kind contributions). 

Executive Summary
This notice identifies the objectives for RCDG program projects, deadlines, funding information, eligibility criteria for projects and applicants, and application forms and associated instructions. NIFA requests applications for grants under the RCDG program for FY 2026 to improve the economic condition of rural areas by helping nonprofit organizations who in turn provide technical assistance to start, expand, or improve cooperatives and mutually owned businesses in rural areas. This notice is being issued to allow applicants sufficient time to leverage financing and prepare and submit their applications.  

Estimated funding amounts are not guaranteed and are subject to the availability of appropriated funds.

Public Health Training Centers (PHTC) Program

Limit: 1 // Tickets Available: 0

K. Reynolds (Community, Environment & Policy)

Limiting Language
You may not submit more than one application. If you submit more than one application, we will only accept the last on-time submission.
Summary
The Public Health Training Centers (PHTC) Program aims to increase the knowledge of the public health workforce through traineeships, specialized training and professional development in partnership with state and local health departments, community-based primary care providers, and related organizations (including non-traditional partners) to address public healthcare needs.

Funding Type
External Deadline
7/17/2026

OVC FY 2026 Increasing Services for American Indian and Alaska Native Victims of Human Trafficking in Urban Centers Program

No Applicants // Limit: 1 (Category 2 only) // Tickets Available: 1

Limiting Language 
You may submit no more than one application in response to this NOFO. You can apply to either Category 1 or Category 2, but not both categories. 

Purpose of the Funding 
The Office of Justice Programs (OJP) is committed to advancing work that furthers the U.S. Department of Justice’s (DOJ) mission to keep our country safe and secure and uphold the rule of law and protect the rights of American citizens. OJP provides federal leadership, funding, and other critical resources to directly support law enforcement, combat violent crime, protect American children, provide services to American crime victims, and address public safety challenges, including human trafficking and the opioid crisis. This is a notice of funding opportunity (NOFO) for the OVC FY2026 Increasing Services for American Indian and Alaska Native Victims of Human Trafficking in Urban Centers Program. This opportunity is intended to increase access to victim services for victims of human trafficking. 

Category 2 Goals and Objectives 
Category 2: Support for Victim Service Providers 

Goal 1: Enhance the capacity of urban Indian-serving organizations to deliver services to AI/AN victims of human trafficking through ongoing guidance and support. 

  • Objective 1: Improve the organizational capacity of funded organizations to provide victim services. 
Research Category
Funding Type
External Deadline
7/23/2026 (Complete and submit SD-424 on Grants.gov), 7/30/2026 (Full Application in JustGrants)

Coccidioidomycosis Collaborative Research Centers (P01 Clinical Trial Not Allowed)

Limit: 1 // Tickets Available: 0

J. Galgiani (Valley Fever Center for Excellence)

Limiting Language
Only one application per institution (normally identified by having a unique entity identifier (UEI) number or NIH IPF number) is allowed.

Funding Opportunity Purpose
The purpose of the notice of funding opportunity (NOFO) is to solicit applications for a Coccidioidomycosis Collaborative Research Centers (CCRC) program. This new initiative will establish highly collaborative, multi-disciplinary, research teams to conduct translational and clinical research to support the development of a Valley fever vaccine as outlined in NIAID’s Strategic Plan for Research to Develop a Valley fever Vaccine.